Literature DB >> 4552555

Bacteriophage lysozyme synthesis in Escherichia coli K-12(lambda) infected with rII mutant of bacteriophage T4.

K K Mark.   

Abstract

When Escherichia coli K-12(lambda) was infected with a T4rII bacteriophage, synthesis of lysozyme appeared at the normal time but stopped 15 min after infection. The lysozyme produced was 1% of the normal level.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4552555      PMCID： PMC356333     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  8 in total

1.  DNA synthesized in Escherichia coli K12 (lambda) after infection with an rII mutant of bacteriophage T4.

Authors:  M NOMURA
Journal:  Virology       Date:  1961-06       Impact factor: 3.616

2.  Physiological effects of rII mutations in bacteriophage T4.

Authors:  A GAREN
Journal:  Virology       Date:  1961-06       Impact factor: 3.616

3.  Nucleic acid synthesis by a lysogenic strain of Escherichia coli infected with an rII mutant of coliphage T2.

Authors:  J F WHITFIELD; K M BAIRD
Journal:  Can J Microbiol       Date:  1959-02       Impact factor: 2.419

4.  A lysozyme assay method for low activity.

Authors:  K K Mark
Journal:  Anal Biochem       Date:  1970-10       Impact factor: 3.365

5.  Replication of T4rII bacteriophage in Escherichia coli K-12 (lambda).

Authors:  C S Buller; L Astrachan
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103

6.  The relationship between the synthesis of DNA and the synthesis of phage lysozyme in Escherichia coli infected by bacteriophage T4.

Authors:  K K Mark
Journal:  Virology       Date:  1970-09       Impact factor: 3.616

7.  Studies on the physiological defect in rII mutants of bacteriophage T4.

Authors:  M Sekiguchi
Journal:  J Mol Biol       Date:  1966-04       Impact factor: 5.469

8.  Bacteriophage-induced functions in Escherichia coli K (lambda) infected with rII mutants of bacteriophage T4.

Authors:  B Rutberg; L Rutberg
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.